Literature DB >> 6124423

Long-term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

S E Husted, H K Nielsen, C K Christensen, O Lederballe Pedersen.   

Abstract

The antihypertensive effect of nifedipine during long-term therapy was investigated in 5 patients receiving nifedipine as the sole drug and in 10 patients who had nifedipine in combination with a beta-adrenoceptor blocking drug. Nifedipine monotherapy was problematic because of side-effects and development of resistance to therapy after a few months. In patients who received the combined therapy significant and stable blood pressure reductions were maintained during the whole observation period (12-33 months). However, the occurrence of peripheral oedema in 4 of the patients necessitated the addition of a thiazide diuretic. It is concluded that nifedipine is not a first choice drug for the long-term treatment of arterial hypertension. When given in addition to a beta-blocker it is well tolerated and powerful but fluid retention may occur and if not counteracted by a diuretic it will limit the antihypertensive potential of the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124423     DOI: 10.1007/bf00542452

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Relationship between the antihypertensive effect and steady-state plasma concentration of nifedipine given alone or in combination with a beta-adrenoceptor blocking agent.

Authors:  O Lederballe Pedersen; C K Christensen; E Mikkelsen; K D Rämsch
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

2.  Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.

Authors:  K Aoki; S Kondo; A Mochizuki; T Yoshida; S Kato; K Kato; K Takikawa
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

3.  Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.

Authors:  M D Guazzi; C Fiorentini; M T Olivari; A Bartorelli; G Necchi; A Polese
Journal:  Circulation       Date:  1980-05       Impact factor: 29.690

4.  Acute and chronic effects of nifedipine in arterial hypertension.

Authors:  O L Pedersen; E Mikkelsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

5.  Changes in plasma volume and extracellular fluid volume and after addition of hydralazine to propranolol treatment in patients with hypertension.

Authors:  H Ibsen; K Rasmussen; H A Jensen; A Leth
Journal:  Acta Med Scand       Date:  1978

6.  Haemodynamics studies in young men with mild blood pressure elevation.

Authors:  R Sannerstedt; R Sivertsson; Y Lundgren
Journal:  Acta Med Scand Suppl       Date:  1976

Review 7.  Calcium blockade as a therapeutic principle in arterial hypertension. Clinical aspects and experimental studies on isolated vessels from spontaneously hypertensive rats and normotensive man.

Authors:  O L Pedersen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981
  7 in total
  18 in total

Review 1.  Renal effects of calcium entry blockers.

Authors:  L M Ruilope; J M Alcazar
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 2.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 3.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

4.  Effect of nifedipine and propranolol on blood flow, venous compliance and blood pressure in essential hypertension.

Authors:  R I Ogilvie
Journal:  Can Med Assoc J       Date:  1985-05-15       Impact factor: 8.262

5.  The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension.

Authors:  N N Stanley; J L Thirkettle; M P Varma; H Larkin; I D Heath
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Acute natriuretic effect of nifedipine in hypertensive patients and normotensive controls--a proximal tubular effect?

Authors:  L R Krusell; C K Christensen; O Lederballe Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Human lymphatic vessel contractile activity is inhibited in vitro but not in vivo by the calcium channel blocker nifedipine.

Authors:  Niklas Telinius; Sheyanth Mohanakumar; Jens Majgaard; Sukhan Kim; Hans Pilegaard; Einar Pahle; Jørn Nielsen; Marc de Leval; Christian Aalkjaer; Vibeke Hjortdal; Donna Briggs Boedtkjer
Journal:  J Physiol       Date:  2014-08-28       Impact factor: 5.182

Review 8.  Treatment of severe hypertension and hypertensive crises with nifedipine.

Authors:  M C Houston
Journal:  West J Med       Date:  1987-06

9.  Efficacy and tolerability of atenolol, nifedipine and their combination in the management of hypertension.

Authors:  N N Stanley; J L Thirkettle; M P Varma; H Larkin; I D Heath
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 10.  Calcium antagonists and exercise performance.

Authors:  W Kindermann
Journal:  Sports Med       Date:  1987 May-Jun       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.